306439
Cool, Minty and Toxic: What to Do About the Problem of Menthol in Tobacco Products
This session will start by describing the public health problems posed by mentholated tobacco products. It will then describe the actions which the FDA has taken (and failed to take) to address this public health crisis. The bulk of the presentation will describe innovative policy approaches that state and local governments could implement to address the burden of menthol. The most direct policy approach would be a state or local government prohibition on the sale of mentholated cigarettes. Yet policy options short of a sales prohibition could also address the issue: restrictions on which establishments can sell mentholated tobacco products, increasing the price of mentholated tobacco products compared to other tobacco products, disclosure requirements, or marketing restrictions. This session will provide units of government with the information they need to prioritize interventions that address this challenging area.
Learning Areas:
Diversity and culturePublic health or related organizational policy, standards, or other guidelines
Public health or related public policy
Learning Objectives:
Describe why menthol poses public health risks beyond those associated with non-flavored tobacco products, particularly for priority populations. Describe actions the FDA has taken (and failed to take) to regulate menthol. Explain local authority to regulate tobacco products. List and explain options for state and local governments to regulate menthol.
Keyword(s): Tobacco Control, Policy/Policy Development
Qualified on the content I am responsible for because: I have been the principal investigator of a research grant on the regulation of menthol cigarettes, have presented on the topic, have published scholarly articles on various tobacco control topics, have worked as a public health attorney for over seven years, and have worked as an adjunct law professor teaching courses in Public Health Law and Legislation.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.